Sodium iodide i-131
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
269 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 7 | 23 | 9 | 1 | 23 | 59 |
| Thyroid diseases | D013959 | — | E00-E07 | 4 | 17 | 4 | 1 | 14 | 37 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | 3 | 1 | — | 4 |
| Hypothyroidism | D007037 | EFO_0004705 | E03.9 | 1 | — | 1 | 1 | 1 | 4 |
| Covid-19 | D000086382 | — | U07.1 | — | — | — | 2 | — | 2 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | 1 | 1 | — | 2 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | — | — | 1 | — | 1 |
| Sars-cov-2 | D000086402 | — | — | — | — | — | 1 | — | 1 |
| Coronavirus | D017934 | — | — | — | — | — | 1 | — | 1 |
| Viral load | D019562 | — | — | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 14 | 33 | 4 | — | 5 | 52 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 11 | 23 | 6 | — | 5 | 43 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 13 | 12 | 3 | — | 10 | 37 |
| Recurrence | D012008 | — | — | 9 | 5 | 1 | — | 2 | 15 |
| Papillary thyroid cancer | D000077273 | — | — | 4 | 9 | 1 | — | 2 | 15 |
| Carcinoma | D002277 | — | C80.0 | 4 | 8 | 1 | — | 3 | 14 |
| Follicular adenocarcinoma | D018263 | — | — | 3 | 8 | 1 | — | — | 11 |
| Follicular lymphoma | D008224 | — | C82 | 3 | 7 | 1 | — | — | 10 |
| B-cell lymphoma | D016393 | — | — | 6 | 4 | 1 | — | — | 10 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 5 | 2 | — | — | 9 |
Show 25 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 14 | 11 | — | — | 1 | 20 |
| Central nervous system neoplasms | D016543 | — | — | 7 | 5 | — | — | 3 | 13 |
| Pheochromocytoma | D010673 | — | — | 3 | 4 | — | — | 7 | 13 |
| Nervous system neoplasms | D009423 | — | — | 7 | 4 | — | — | 1 | 10 |
| Papillary carcinoma | D002291 | — | — | 1 | 7 | — | — | 1 | 8 |
| Paraganglioma | D010235 | — | — | 3 | 2 | — | — | 4 | 8 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 4 | 4 | — | — | — | 7 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 2 | 6 | — | — | — | 7 |
| Adenocarcinoma | D000230 | — | — | 5 | 2 | — | — | — | 6 |
| Multiple myeloma | D009101 | — | C90.0 | 4 | 3 | — | — | — | 6 |
Show 54 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 7 | — | — | — | — | 7 |
| Syndrome | D013577 | — | — | 1 | — | — | — | 4 | 5 |
| T-cell lymphoma | D016399 | — | — | 3 | — | — | — | — | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | — | — | — | — | 3 |
| T-cell lymphoma peripheral | D016411 | — | — | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
| Ewing sarcoma | D012512 | EFO_0000173 | — | 1 | — | — | — | 1 | 2 |
| Rhabdomyosarcoma | D012208 | — | — | 1 | — | — | — | 1 | 2 |
| Triple negative breast neoplasms | D064726 | — | — | 2 | — | — | — | — | 2 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | — | — | — | — | 2 |
Show 31 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | — | — | — | 5 | 5 |
| Tachycardia | D013610 | — | R00.0 | — | — | — | — | 5 | 5 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 4 | 4 |
| Orthostatic intolerance | D054971 | — | — | — | — | — | — | 2 | 2 |
| Xerostomia | D014987 | — | K11.7 | — | — | — | — | 2 | 2 |
| Hypovolemia | D020896 | — | E86 | — | — | — | — | 1 | 1 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 1 | 1 |
| Nervous system diseases | D009422 | — | G00-G99 | — | — | — | — | 1 | 1 |
Show 21 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 11,916 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
8,516 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use